The Royal Surrey is the country’s fourth largest cancer centre, treating more than 8,000 patients each year across the South East of England.
It delivers 4,000 chemotherapy treatments, almost 3,500 sessions of radiotherapy, and over 2,000 cancer surgeries annually.
The Trust performed just three robotic surgeries in the first year but said the programme has grown into one of the busiest and most advanced in the country.
In 2024, more than 1,500 patients benefitted from robotic surgery, with the Trust saying it performed more prostate surgeries than any other single-site hospital in the UK.
Consultant Ear Nose and Throat surgeon David Walker said: “For many years we’ve been ahead of the curve in terms of driving better technologies for patients and we know that this creates better outcomes.”
The robot does not replace surgeons but enhances their ability to carry out complex operations via very tiny incisions, with greater accuracy and precision.
The surgeon operates the robot from a control console, performing the procedure using a minimally invasive approach, also known as keyhole surgery.
Patients benefit from faster recovery, shorter hospital stays, better outcomes and less complications while it also helps the hospital improve efficiency and save bed days.